Celcuity Inc. Profile Avatar - Palmy Investing

Celcuity Inc.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the …

Biotechnology
US, Minneapolis [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Celcuity Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CELC's Analysis
CIK: 1603454 CUSIP: 15102K100 ISIN: US15102K1007 LEI: - UEI: -
Secondary Listings
CELC has no secondary listings inside our databases.